BioXcel Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: BioXcel Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: BioXcel Therapeutics Inc
Rating: 2.05100
Author: Trendlyne DVM scores

about

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

2.01 0.11 (5.79%)

70.57% Fall from 52W High

293.0K

XNAS Volume

XNAS 08 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for BioXcel Therapeutics Inc is on 15 Jul 2025 for the purpose of BioXcel Therapeutics Inc Annual General Meeting for 2025 See details